- ►annals.org [PDF] DG Altman, KF Schulz, D Moher, M Egger, F … - Annals of Internal …, 2001 - Am Coll Physicians Overwhelming evidence now indicates that the quality of report- ing of randomized, controlled
trials (RCTs) is less than optimal. Recent methodologic analyses indicate that inadequate reporting
and design are associated with biased estimates of treatment effects. Such systematic ... Cited by 1402 - Related articles - BL Direct - All 50 versions
- ►rsna.org PM Bossuyt, JB Reitsma, DE Bruns, CA Gatsonis, PP … - Clinical Radiology, 2003 - Elsevier METHODS: The standards for reporting of diagnostic accuracy (STARD) steering committee
searched the literature to identify publications on the appropriate conduct and reporting of diagnostic
studies and extracted potential items into an extensive list. Researchers, editors, and ... Cited by 1064 - Related articles - BL Direct - All 63 versions
- ►bmj.com [PDF] J Lexchin, LA Bero, B Djulbegovic, O Clark - British Medical Journal, 2003 - bmj.com Objective To investigate whether funding of drug studies by the pharmaceutical industry is associated
with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical
companies differ from the methods in trials with other sources of support. Methods ... Cited by 732 - Related articles - BL Direct - All 13 versions
- ►evms.edu [PDF] L Holmberg, A Bill-Axelson, F Helgesen, JO … - The New England …, 2002 - nejm.highwire.org Results During a median of 6.2 years of follow-up, 62 men in the watchful-waiting group and
53 in the radical-prostatectomy group died (P=0.31). Death due to prostate cancer occurred in
31 of 348 of those assigned to watchful waiting (8.9 percent) and in 16 of 347 of those ... Cited by 576 - Related articles - BL Direct - All 17 versions
- ►ahajournals.org AJ Taylor, LE Sullenberger, HJ Lee, JK Lee, KA Grace - Circulation, 2004 - Am Heart Assoc Methods and Results— This was a double-blind randomized placebo-controlled study of
once-daily extended-release niacin (1000 mg) added to background statin therapy in 167 patients
(mean age 67 years) with known coronary heart disease and low levels of high-density ... Cited by 538 - Related articles - All 6 versions
JPA Ioannidis - medicine.plosjournals.org There is increasing concern that most current published research findings are false. The probability
that a research claim is true may depend on study power and bias, the number of other studies
on the same question, and, importantly, the ratio of true to no relationships among the ... Cited by 499 - Related articles - Cached - BL Direct - All 81 versions
- ►psychrights.org [PDF] AW Chan, A Hrobjartsson, MT Haahr, PC Gotzsche, DG … - Jama, 2004 - Am Med Assoc Design Cohort study using protocols and published reports of randomized trials approved by
the Scientific-Ethical Committees for Copenhagen and Frederiksberg, Denmark, in
1994-1995. The number and characteristics of reported and unreported trial outcomes ... Cited by 458 - Related articles - BL Direct - All 8 versions
- ►ajph.org RE Glasgow, E Lichtenstein, AC … - American Journal of …, 2003 - Am Public Health Assoc The gap between research and practice is well documented. We address one of the underlying
reasons for this gap: the assumption that effectiveness research naturally and logically follows
from successful efficacy research. These 2 research traditions have evolved different ... Cited by 396 - Related articles - BL Direct - All 14 versions
- ►bmj.com JAC Sterne, M Egger, GD Smith - British Medical Journal, 2001 - bmj.com All these biases are more likely to affect small studies than large ones. The smaller a study the
larger the treatment effect necessary for the results to be significant. The greater investment of
time and money in larger studies means that they are more likely to be of high ... Cited by 340 - Related articles - BL Direct - All 10 versions
- ►oxfordjournals.org LM McShane, DG Altman, W Sauerbrei, SE Taube, … - European Journal of …, 2005 - Elsevier Despite years of research and hundreds of reports on tumour markers in oncology, the number
of markers that have emerged as clinically useful is pitifully small. Often initially reported studies
of a marker show great promise, but subsequent studies on the same or related markers ... Cited by 349 - Related articles - BL Direct - All 27 versions
